Repeated treatment with SZ-A dose-dependently inhibited the expression of TGF-β1 in the kidneys of diabetic ZDF rats, indicating that the primary mechanism of SZ-A improving renal fibrosis lies in inhibiting TGF-β1 signaling. Here, TGFB1 is linked to renal fibrosis.